{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:53:18Z","timestamp":1778903598247,"version":"3.51.4"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Priapism is a major clinical complication of sickle cell disease (SCD), with severe sexual, reproductive, and mental health impact. There are currently no consensus diagnostic biomarkers for identifying individuals with SCD at risk of priapism before its occurrence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To systematically review the biochemical, hematological, imaging, genetic, and rheological parameters associated with priapism occurrence among individuals with SCD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A systematic literature search for studies investigating the association of biochemical, hematological, rheological, imaging, rheological, and genetic parameters with the occurrence of priapism in individuals with SCD was performed in the MEDLINE, Embase, and Cochrane databases, using the following terms: \u201cpriapism,\u201d \u201csickle cell,\u201d \u201cbiomarker,\u201d \u201cmarker,\u201d \u201claboratory,\u201d \u201cradiographic,\u201d \u201cdiagnostic,\u201d and \u201cpredictive.\u201d A systematic review of the identified studies was conducted to describe the landscape of priapism-related biomarkers in individuals with SCD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 358 studies were identified, of which 14 studies were eventually selected for evidence synthesis. The selected studies were published between 2005 and 2023, with authorship spanning five continents. We identified multiple clinical parameters investigated as potential biomarker candidates for their association with priapism occurrence in patients with SCD. We classified these into biochemical (lactate dehydrogenase, bilirubin, aspartate transaminase, alanine transaminase, alkaline phosphatase, nitric oxide metabolites, interleukin 6), hematological (hemoglobin concentration, mean corpuscular volume, mean corpuscular hemoglobin, reticulocyte count, leukocyte count), genetic (Klotho, TGFBR3, QAP1, ITGAV, LNC02537, NAALADL2), rheological (red blood cell deformability, aggregation index, augmentation index), and imaging parameters. However, the results were often contradictory and do not support the clinical application of any of the investigated parameters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Several clinical and laboratory parameters have been associated with priapism occurrence in SCD; however, contradictory findings across geographical locations paint an unreliable picture of their clinical utility. Additional studies are needed to generate enough level 1 evidence in support of any of the current candidates.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/sxmrev\/qeaf004","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T12:24:28Z","timestamp":1738239868000},"page":"246-255","source":"Crossref","is-referenced-by-count":1,"title":["Priapism-related biomarkers in sickle cell disease: a systematic review"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8716-7457","authenticated-orcid":false,"given":"Oluwafolajimi","family":"Adesanya","sequence":"first","affiliation":[{"name":"Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine , Baltimore, MD 21287-2101,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur L","family":"Burnett","sequence":"additional","affiliation":[{"name":"Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine , Baltimore, MD 21287-2101,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"1","key":"2025041607171219000_ref1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/JU.0000000000002767","article-title":"The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: an AUA\/SMSNA guideline","volume":"208","author":"Bivalacqua","year":"2022","journal-title":"J Urol."},{"issue":"9","key":"2025041607171219000_ref2","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1046\/j.1464-410x.2002.03022.x","article-title":"Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int."},{"issue":"3","key":"2025041607171219000_ref3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0022-5347(05)65841-7","article-title":"Genitourinary complications of sickle cell disease","volume":"166","author":"Bruno","year":"2001","journal-title":"J Urol."},{"issue":"1","key":"2025041607171219000_ref4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0022-5347(17)38248-4","article-title":"Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae","volume":"145","author":"Fowler","year":"1991","journal-title":"J Urol."},{"issue":"1","key":"2025041607171219000_ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5534\/wjmh.2016.34.1.1","article-title":"Clinical management of priapism: a review","volume":"34","author":"Shigehara","year":"2016","journal-title":"World J Mens Health."},{"issue":"5","key":"2025041607171219000_ref6","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/JU.0000000000002236","article-title":"Acute ischemic priapism: an AUA\/SMSNA guideline","volume":"206","author":"Bivalacqua","year":"2021","journal-title":"J Urol."},{"issue":"3","key":"2025041607171219000_ref7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/jsm.12816","article-title":"Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors","volume":"12","author":"Anele","year":"2015","journal-title":"J Sex Med."},{"issue":"5","key":"2025041607171219000_ref8","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group","year":"2010","journal-title":"Int J Surg Lond Engl."},{"issue":"1","key":"2025041607171219000_ref9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev."},{"key":"2025041607171219000_ref10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/9780470712184.ch5","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"O\u2019Connor","year":"2008"},{"issue":"9","key":"2025041607171219000_ref11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol."},{"key":"2025041607171219000_ref12","volume-title":"RoB 2: a revised Cochrane risk-of-bias tool for randomized trials | Cochrane Bias","author":"Cochrane Collaboration","year":"2011"},{"key":"2025041607171219000_ref13","author":"Kato"},{"issue":"1","key":"2025041607171219000_ref14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1535370219892846","article-title":"Clinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patients","volume":"245","author":"Alkindi","year":"2020","journal-title":"Exp Biol Med Maywood NJ."},{"issue":"5","key":"2025041607171219000_ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154866","article-title":"Men with sickle cell anemia and priapism exhibit increased hemolytic rate, decreased red blood cell deformability and increased red blood cell aggregate strength","volume":"11","author":"Cita","year":"2016","journal-title":"PLoS ONE."},{"issue":"6","key":"2025041607171219000_ref16","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood."},{"issue":"9","key":"2025041607171219000_ref17","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1182\/blood-2005-04-1594","article-title":"Hemolysis-associated priapism in sickle cell disease","volume":"106","author":"Nolan","year":"2005","journal-title":"Blood."},{"issue":"2","key":"2025041607171219000_ref18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12291-011-0162-y","article-title":"Biochemical indicator of sickle cell disease: preliminary report from India","volume":"27","author":"Pandey","year":"2012","journal-title":"Indian J Clin Biochem."},{"issue":"2","key":"2025041607171219000_ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246067","article-title":"Priapism in sickle cell disease: associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers","volume":"16","author":"Figueiredo","year":"2021","journal-title":"PLoS ONE."},{"issue":"3","key":"2025041607171219000_ref20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000360608","article-title":"Priapism in homozygous sickle cell patients: important clinical and laboratory associations","volume":"23","author":"Madu","year":"2014","journal-title":"Med Princ Pract Int J Kuwait Univ Health Sci Cent."},{"issue":"12","key":"2025041607171219000_ref21","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.jsxm.2019.09.012","article-title":"Clinical and genetic predictors of priapism in sickle cell disease: results from the recipient epidemiology and donor evaluation study III Brazil cohort study","volume":"16","author":"Ozahata","year":"2019","journal-title":"J Sex Med."},{"issue":"1","key":"2025041607171219000_ref22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev."},{"key":"2025041607171219000_ref23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/VHRM.S163228","article-title":"Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana","volume":"2018","author":"Antwi-Boasiako","year":"2018","journal-title":"Vasc Health Risk Manag."},{"issue":"4","key":"2025041607171219000_ref24","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/archinte.1974.00320160118010","article-title":"Hemolysis in sickle cell disease","volume":"133","author":"Bensinger","year":"1974","journal-title":"Arch Intern Med."},{"issue":"5","key":"2025041607171219000_ref25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00277-020-03978-8","article-title":"High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia","volume":"99","author":"Domingos","year":"2020","journal-title":"Ann Hematol."},{"issue":"3","key":"2025041607171219000_ref26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1365-2141.2007.06560.x","article-title":"Genetic polymorphisms associated with priapism in sickle cell disease","volume":"137","author":"Elliott","year":"2007","journal-title":"Br J Haematol."},{"issue":"2","key":"2025041607171219000_ref27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2141.2004.05295.x","article-title":"Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia","volume":"128","author":"Nolan","year":"2005","journal-title":"Br J Haematol."},{"issue":"6655","key":"2025041607171219000_ref28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature."},{"issue":"4","key":"2025041607171219000_ref29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/s1568-1637(02)00027-2","article-title":"Klotho: a fundamental regulator of aging","volume":"1","author":"Nabeshima","year":"2002","journal-title":"Ageing Res Rev."},{"issue":"2","key":"2025041607171219000_ref30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1254\/jjp.89.149","article-title":"Production of nitric oxide, but not prostacyclin, is reduced in klotho mice","volume":"89","author":"Nakamura","year":"2002","journal-title":"Jpn J Pharmacol."},{"issue":"6","key":"2025041607171219000_ref31","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1291\/hypres.24.705","article-title":"Troglitazone improves endothelial function and augments renal klotho mRNA expression in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with multiple atherogenic risk factors","volume":"24","author":"Yamagishi","year":"2001","journal-title":"Hypertens Res Off J Jpn Soc Hypertens."},{"issue":"5","key":"2025041607171219000_ref32","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s000180050038","article-title":"Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases","volume":"57","author":"Nagai","year":"2000","journal-title":"Cell Mol Life Sci CMLS."},{"issue":"5410","key":"2025041607171219000_ref33","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1126\/science.283.5410.2080","article-title":"Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart","volume":"283","author":"Brown","year":"1999","journal-title":"Science."},{"issue":"3","key":"2025041607171219000_ref34","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1074\/jbc.271.3.1309","article-title":"Functional analysis of aquaporin-1 deficient red cells. The Colton-null phenotype","volume":"271","author":"Mathai","year":"1996","journal-title":"J Biol Chem."},{"issue":"2","key":"2025041607171219000_ref35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1182\/blood.V95.2.368","article-title":"Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor","volume":"95","author":"Kaul","year":"2000","journal-title":"Blood."},{"issue":"12","key":"2025041607171219000_ref36","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1182\/blood-2004-01-0042","article-title":"Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions","volume":"104","author":"Zennadi","year":"2004","journal-title":"Blood."},{"key":"2025041607171219000_ref37","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.2147\/CMAR.S177327","article-title":"lncRNA LOC100132354 promotes angiogenesis through VEGFA\/VEGFR2 signaling pathway in lung adenocarcinoma","volume":"2018","author":"Wang","year":"2018","journal-title":"Cancer Manag Res."},{"issue":"2","key":"2025041607171219000_ref38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005874","article-title":"Six novel loci associated with circulating VEGF levels identified by a meta-analysis of genome-wide association studies","volume":"12","author":"Choi","year":"2016","journal-title":"PLoS Genet."},{"key":"2025041607171219000_ref39","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3852401","article-title":"Circulating levels of omentin, leptin, VEGF, and HGF and their clinical relevance with PSA marker in prostate cancer","volume":"2018","author":"Fryczkowski","year":"2018","journal-title":"Dis Markers."},{"issue":"8","key":"2025041607171219000_ref40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198055","article-title":"Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer","volume":"13","author":"Ye","year":"2018","journal-title":"PloS One."},{"issue":"1","key":"2025041607171219000_ref41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000319","article-title":"A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease","volume":"5","author":"Burgner","year":"2009","journal-title":"PLoS Genet."},{"issue":"45","key":"2025041607171219000_ref42","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1038\/onc.2013.464","article-title":"N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype","volume":"33","author":"Whitaker","year":"2014","journal-title":"Oncogene."},{"issue":"1","key":"2025041607171219000_ref43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2350-14-36","article-title":"A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosis","volume":"14","author":"Greliche","year":"2013","journal-title":"BMC Med Genet."},{"issue":"2","key":"2025041607171219000_ref44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/1535370219900494","article-title":"Blood rheology biomarkers in sickle cell disease","volume":"245","author":"Lu","year":"2020","journal-title":"Exp Biol Med Maywood NJ."},{"key":"2025041607171219000_ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.722896","article-title":"Deformability of stored red blood cells","volume":"2021","author":"Barshtein","year":"2021","journal-title":"Front Physiol."},{"issue":"1-2","key":"2025041607171219000_ref46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3233\/CH-2012-1573","article-title":"Erythrocyte aggregation: basic aspects and clinical importance","volume":"53","author":"Baskurt","year":"2013","journal-title":"Clin Hemorheol Microcirc."},{"issue":"13","key":"2025041607171219000_ref47","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.115.021015","article-title":"Arterial stiffness impairment in sickle cell disease associated with chronic vascular complications: the multinational African CADRE study","volume":"134","author":"Ranque","year":"2016","journal-title":"Circulation."},{"issue":"2","key":"2025041607171219000_ref48","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jsm.12756","volume":"12","author":"Patel","year":"2015","journal-title":"J Sex Med."},{"issue":"1","key":"2025041607171219000_ref49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Annu Rev Pathol."},{"issue":"1","key":"2025041607171219000_ref50","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1016\/j.bbmt.2009.10.001","article-title":"Severe sickle cell disease \u2013 pathophysiology and therapy","volume":"16","author":"Buchanan","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"issue":"3","key":"2025041607171219000_ref51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp Biol Med."},{"issue":"1","key":"2025041607171219000_ref52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40425-016-0179-0","article-title":"Validation of biomarkers to predict response to immunotherapy in cancer: volume II - clinical validation and regulatory considerations","volume":"4","author":"Dobbin","year":"2016","journal-title":"J Immunother Cancer."},{"issue":"10","key":"2025041607171219000_ref53","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.4103\/jfmpc.jfmpc_668_19","article-title":"Does aging have an impact on hemoglobin? Study in elderly population at rural teaching hospital","volume":"8","author":"Raisinghani","year":"2019","journal-title":"J Fam Med Prim Care."},{"issue":"1","key":"2025041607171219000_ref54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.prrv.2013.11.003","article-title":"Differences in the clinical and genotypic presentation of sickle cell disease around the world","volume":"15","author":"Saraf","year":"2014","journal-title":"Paediatr Respir Rev."},{"issue":"1","key":"2025041607171219000_ref55","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1038\/s41598-020-59258-y","article-title":"Predictors of impending acute chest syndrome in patients with sickle cell anaemia","volume":"10","author":"Alkindi","year":"2020","journal-title":"Sci Rep."},{"issue":"5","key":"2025041607171219000_ref56","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14980","article-title":"Clinical and laboratory predictors of painful vaso-occlusive crisis among sickle cell disease patients: a single-center study in Saudi Arabia","volume":"13","author":"Zakaria","year":"2021","journal-title":"Cureus."},{"issue":"11","key":"2025041607171219000_ref57","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/jcm8111839","article-title":"Identification of clinical and laboratory parameters associated with the development of acute chest syndrome during vaso-occlusive episodes in children with sickle cell disease: a preliminary step before assessing specific and early treatment strategies","volume":"8","author":"Madhi","year":"2019","journal-title":"J Clin Med."},{"issue":"5","key":"2025041607171219000_ref58","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2174\/1389450115666141111111842","article-title":"Molecular pathophysiology of priapism: emerging targets","volume":"16","author":"Anele","year":"2015","journal-title":"Curr Drug Targets."}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/13\/2\/246\/61780150\/qeaf004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/13\/2\/246\/61780150\/qeaf004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T11:17:45Z","timestamp":1744802265000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smr\/article\/13\/2\/246\/8003911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,7]]},"published-print":{"date-parts":[[2025,4,14]]}},"URL":"https:\/\/doi.org\/10.1093\/sxmrev\/qeaf004","relation":{},"ISSN":["2050-0513","2050-0521"],"issn-type":[{"value":"2050-0513","type":"print"},{"value":"2050-0521","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,2,7]]}}}